Dipòsit Digital de Documents de la UAB 3 registres trobats  La cerca s'ha fet en 0.00 segons. 
1.
17 p, 5.0 MB Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer / Sequeiros, Tamara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rigau, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Chiva, Cristina (Proteomics Unit, Universitat Pompeu Fabra, Barcelona, Spain) ; Montes, Melania (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Garcia-Grau, Iolanda (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Garcia, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Diaz, Sherley (Hospital Universitari Vall d'Hebron) ; Celma, Ana (Hospital Universitari Vall d'Hebron) ; Bijnsdorp, Irene (Department of Urology, VU University Medical Center, Amsterdam, The Netherlands) ; Campos, Alex (Sanford-Burnham Medical Research Institute, La Jolla, California, USA) ; Di Mauro, Primiano (Sagetis-Biotech; Grup d'Enginyeria de Materials (GEMAT) Institut Químic de Sarrià, Barcelona, Spain) ; Borrós, Salvador (Sagetis-Biotech; Grup d'Enginyeria de Materials (GEMAT) Institut Químic de Sarrià, Barcelona, Spain) ; Reventós, Jaume (IDIBELL-Bellvitge Biomedical Research Institute, Barcelona, Spain) ; Doll, Andreas (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Paciucci, Rosanna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pegtel, Michiel (Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands) ; de Torres, Inés (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sabidó, Eduard (Proteomics Unit, Universitat Pompeu Fabra, Barcelona, Spain) ; Morote Robles, Juan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Olivan, Mireia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Rapid and reliable diagnosis of prostate cancer (PCa) is highly desirable as current used methods lack specificity. In addition, identification of PCa biomarkers that can classify patients into high- and low-risk groups for disease progression at early stage will improve treatment decision-making. [...]
2016 - 10.18632/oncotarget.13634
Oncotarget, Vol. 8 (november 2016) , p. 4960-4976  
2.
30 p, 2.0 MB The Present and Future of Prostate Cancer Urine Biomarkers / Rigau, Marina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Olivan, Mireia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Garcia, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sequeiros, Tamara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montes, Melania (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Colás, Eva (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Llauradó, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Planas, Jacques (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; de Torres, Inés (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ; Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ; Cooper, Colin (Cancer Genetics, University of East Anglia, Norwich Norfolk, NR4 7TJ, UK; E-Mails: (C.C.); (J.C.)) ; Reventós, Jaume (Department of Basic Sciences, International University of Catalonia, 08017 Barcelona, Spain) ; Clark, Jeremy (Cancer Genetics, University of East Anglia, Norwich Norfolk, NR4 7TJ, UK; E-Mails: (C.C.); (J.C.)) ; Doll, Andreas (Hospital Universitari Vall d'Hebron. Institut de Recerca)
In order to successfully cure patients with prostate cancer (PCa), it is important to detect the disease at an early stage. The existing clinical biomarkers for PCa are not ideal, since they cannot specifically differentiate between those patients who should be treated immediately and those who should avoid over-treatment. [...]
2013 - 10.3390/ijms140612620
International journal of molecular sciences, Vol. 14 (june 2013) , p. 12620-12649  
3.
179 p, 3.3 MB MicroRNAs as predictors and therapy for prostate cancer / Montes Pérez, Melania ; Reventós i Puigjaner, Jaume, dir. ; Morote Robles, Juan, dir. ; Olivan Riera, Mireia, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
Prostate cancer (PC) is the most common neoplasia among males from developed countries and the second leading cause of death from cancer in these males. During the last years, serum prostate specific antigen (PSA) has been used as biomarker for PC diagnosis. [...]
Bellaterra : Universitat Autònoma de Barcelona, 2015  

Vegeu també: autors amb noms similars
2 Montes, M.
1 Montes, Marcos
1 Montes, Maria
1 Montes, Maria Teresa
2 Montes, Melanie
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.